FDA Gives Marketing Clearance to Innovative Laser-Drug Cancer Treatment; Laserscope to Market Lasers and Devices for New QLT/Sanofi Winthrop Collaboration.
Business Wire › January 11, 1996
Linked as:
Extract
FDA Gives Marketing Clearance to Innovative Laser-Drug Cancer Treatment; Laserscope to Market Lasers and Devices for New QLT/Sanofi Winthrop Collaboration.
SAN JOSE, Calif.--(BUSINESS WIRE)--Jan. 11, 1996--Laserscope (NASDAQ:LSCP) announced that marketing clearance has been received from the U.S. Food and Drug Administration (FDA) for an innovative Photodynamic Therapy (PDT) application utilizing it...
See the full content of this document
Sponsored links
